Four prolyl endopeptidase inhibitors isolated from actinomycetes, name
d propeptin, SNA-8073-B, staurosporine, and enduracidin were classifie
d into 3 groups on the basis of their inhibition potency against proly
l endopeptidase from a bacterium (Flavobacterium) and a mammal (human
placenta). Staurosporine inhibited the enzyme from Flavobacterium more
strongly than that from human placenta. Enduracidin inhibited the enz
yme from human placenta more strongly than that from Flavobacterium. P
ropeptin and SNA-8073-B, both new compounds, inhibited the enzymes fro
m both origins to the same extent.